ArticleMolecular therapy oncolytics2021

Therapeutically targeting oncogenic CRCs facilitates induced differentiation of NB by RA and the BET bromodomain inhibitor.

Satyanarayana Alleboina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.